I am a
Home I AM A Search Login

Papers of the Week


January 27, 2023


Exp Dermatol


http://www.ncbi.nlm.nih.gov/pubmed/36691705?dopt=Abstract

Efficacy and Safety of Topical JAK inhibitors in the Treatment of Atopic Dermatitis in Pediatrics and Adults: A Systematic Review.

Abstract

Atopic dermatitis (AD) is the most common skin inflammatory disease. Dysregulation of innate and adaptive immune systems plays a major role in the pathophysiology of AD. JAKi (Janus Kinase Inhibitors) reduce the production of pro-inflammatory cytokines and represent a promising novel treatment for AD.